Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report)'s stock price rose 7% during mid-day trading on Tuesday . The company traded as high as $6.88 and last traded at $6.79. Approximately 498,828 shares traded hands during trading, a decline of 75% from the average daily volume of 2,007,482 shares. The stock had previously closed at $6.34.
Wall Street Analysts Forecast Growth
ASPN has been the topic of a number of recent analyst reports. Barclays reiterated an "equal weight" rating and issued a $7.00 price objective (down from $13.00) on shares of Aspen Aerogels in a research report on Thursday, May 29th. Oppenheimer cut shares of Aspen Aerogels from an "outperform" rating to a "market perform" rating in a report on Thursday, May 8th. One analyst has rated the stock with a sell rating, three have given a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $18.44.
Check Out Our Latest Stock Report on Aspen Aerogels
Aspen Aerogels Stock Performance
The company has a quick ratio of 3.53, a current ratio of 4.22 and a debt-to-equity ratio of 0.40. The firm has a market cap of $560.81 million, a P/E ratio of -1.96 and a beta of 2.65. The business has a fifty day simple moving average of $6.07 and a 200-day simple moving average of $7.79.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its earnings results on Thursday, May 8th. The construction company reported ($0.06) earnings per share for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. Aspen Aerogels had a negative net margin of 65.47% and a positive return on equity of 6.69%. The firm had revenue of $78.72 million for the quarter, compared to the consensus estimate of $82.75 million. During the same period in the prior year, the firm earned ($0.02) EPS. The company's revenue was down 16.7% compared to the same quarter last year. On average, sell-side analysts predict that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.
Insider Activity
In related news, CEO Donald R. Young purchased 20,000 shares of the business's stock in a transaction that occurred on Monday, May 12th. The shares were bought at an average price of $5.35 per share, for a total transaction of $107,000.00. Following the purchase, the chief executive officer directly owned 550,856 shares of the company's stock, valued at approximately $2,947,079.60. This represents a 3.77% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 4.30% of the company's stock.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in the stock. GAMMA Investing LLC increased its holdings in shares of Aspen Aerogels by 1,998.7% during the first quarter. GAMMA Investing LLC now owns 3,316 shares of the construction company's stock valued at $210,000 after acquiring an additional 3,158 shares in the last quarter. Acadian Asset Management LLC bought a new stake in Aspen Aerogels during the 1st quarter valued at about $43,000. Banque Cantonale Vaudoise purchased a new position in Aspen Aerogels in the first quarter worth about $45,000. Exchange Traded Concepts LLC lifted its stake in shares of Aspen Aerogels by 460.4% in the first quarter. Exchange Traded Concepts LLC now owns 7,436 shares of the construction company's stock worth $48,000 after buying an additional 6,109 shares in the last quarter. Finally, Sandia Investment Management LP purchased a new stake in shares of Aspen Aerogels during the fourth quarter valued at approximately $89,000. Hedge funds and other institutional investors own 97.64% of the company's stock.
About Aspen Aerogels
(
Get Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Featured Stories
Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
